Last 624.95 INR
Change Today 0.00 / 0.00%
Volume 0.0
ARTD On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

aarti drugs ltd (ARTD) Snapshot

Open
622.00
Previous Close
624.50
Day High
634.00
Day Low
617.00
52 Week High
07/31/14 - 648.95
52 Week Low
08/28/13 - 150.25
Market Cap
7.3B
Average Volume 10 Days
19.5K
EPS TTM
17.91
Shares Outstanding
11.7M
EX-Date
07/2/14
P/E TM
34.9x
Dividend
13.00
Dividend Yield
2.08%
Current Stock Chart for AARTI DRUGS LTD (ARTD)

Related News

No related news articles were found.

aarti drugs ltd (ARTD) Related Businessweek News

No Related Businessweek News Found

aarti drugs ltd (ARTD) Details

Aarti Drugs Limited is engaged in pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti inflammatory, cardioprotectant, antidiarrhoeals/antiprotozoles, antifungals, antiarthritis/osteoporosis, antihistamine, antibiotic, antidiabetic, alzheimer’s treatment, antihypertensive, antiBPH, sedative, vitamins, traquilizar, and antipsychotic. It also provides steroids, such as hydrocortisone sodium succinate sterile and hydrocortisone acetate; pharmaceutical intermediate products comprising valsartan, capecitabine, celecoxib, raloxifene, ketoconazole, and ziprasidone; and specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, methyl nicotinate, N-methyl methane sulphonamide, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, and para toluene sulphonyl chloride. In addition, the company’s products under development comprises Telmisartan for the treatment of cardiovascular diseases; Topiramate for anticonvulsant; Aripiprazole for the treatment of antipsychotic; Acamprosate for alcoholism treatment; Hydralazine HCl and Labetalol for the treatment of antihypertensive; Propafenone HCl for antiarrhythmic treatment; and Ticonazole for use as an antifungal. It also exports its products to 97 countries, as well as offers contract manufacturing services. Aarti Drugs Limited was founded in 1984 and is based in Mumbai, India.

Founded in 1984

aarti drugs ltd (ARTD) Top Compensated Officers

Chairman, Managing Director, Chief Executive ...
Total Annual Compensation: 5.8M
Joint Managing Director, Executive Director, ...
Total Annual Compensation: 5.0M
Whole-Time Director, Member of Share Transfer...
Total Annual Compensation: 5.0M
Whole-Time Director, Member of Share Transfer...
Total Annual Compensation: 4.9M
Whole-Time Director
Total Annual Compensation: 484.1K
Compensation as of Fiscal Year 2014.

aarti drugs ltd (ARTD) Key Developments

Aarti Drugs Limited, Board Meeting, Jul 07, 2014

Aarti Drugs Limited, Board Meeting, Jul 07, 2014. Agenda: To consider the proposal to acquire an undertaking/company at Baddi in Himachal Pradesh to cater its existing business of Toll manufacturing of formulations as an initiative to have its own facilities for this business subject to necessary diligences and approval processes.

Aarti Drugs Seeks Acquisitions In Himachal Pradesh

Aarti Drugs Limited (BSE:524348) is considering a proposal to acquire an undertaking or a company at Baddi in Himachal Pradesh which is subject to necessary due diligence and approvals.

Aarti Drugs Limited, Board Meeting, Jul 11, 2014

Aarti Drugs Limited, Board Meeting, Jul 11, 2014. Agenda: To consider AGM.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARTD:IN 624.95 INR +0.45

ARTD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ARTD.
View Industry Companies
 

Industry Analysis

ARTD

Industry Average

Valuation ARTD Industry Range
Price/Earnings 12.5x
Price/Sales 0.8x
Price/Book 3.0x
Price/Cash Flow 8.5x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AARTI DRUGS LTD, please visit www.aartidrugs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.